Journal article
Phase II study of subcutaneous alemtuzumab (Campath-1H) therapy of patients with previously untreated chronic lymphocytic leukemia (CLL).
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- BLOOD
- Volume:
- 98
- Issue:
- 11
- Pages:
- 772A-772A
- Publication date:
- 2001-11-16
- ISSN:
-
0006-4971
- Source identifiers:
-
30998
Item Description
- Pubs id:
-
pubs:30998
- UUID:
-
uuid:9cabf927-2488-4a5a-b18a-b4c10106a696
- Local pid:
- pubs:30998
- Deposit date:
- 2012-12-19
Terms of use
- Copyright date:
- 2001
If you are the owner of this record, you can report an update to it here: Report update to this record